Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.45    0.00 (0.00%)
Bid:
5.30
Ask:
5.60
Spread: 0.30 (5.66%)
Market Cap: £14.02m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

MicroSalt Operational Update

22 Mar 2023 07:00

RNS Number : 7791T
Tekcapital plc
22 March 2023
 

22 March 2023

Tekcapital Plc

("Tekcapital" or the "Group")

Portfolio Company Update: MicroSalt, Ltd. ("MicroSalt")

Operational Update

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to provide an operationalupdate from Microsalt Ltd ("Microsalt").

B2C Progress;

· SaltMe Crisps continue to be sold throughout the Kroger group. SaltMe Crisps are currently stocked in Kroger stores with efforts continuing to secure new store placements.

As announced on 13 March 2023, Hanahreum Group ("H Mart"), one of the fastest growing retailers in United States has agreed to carry MicroSalt's SaltMe® branded crisps.

Since launching in September 2022, MicroSalt Shakers are currently stocked in over 500 stores.

AS announced on 06 February 2023, MicroSalt is currently working with US Salt LLC for in store sales of products across the US Salt system. US Salt LLC is a leading direct supplier of canister salt to the US retail industry.

E-commerce progress;

First e-commerce sales of MicroSalt Shakers have been encouraging.

E-commerce sales of SaltMe Crisps have also been increasing.

Microsalt is preparing to launch its fourth flavour in a 1 oz size to compliment the current product offering and to create a better variety pack.

Medical Outreach campaign progress;

Direct outreach with free 1 oz shakers samples for the medical community.

Launched direct marketing campaign for shakers in March 2023 in partnership with the National Pancreas Foundation which includes access to approximately 100,000 medical professionals and 170 hospitals.

B2B progress:

· Successfully completed comprehensive testing of Microsalt with several major food companies. MicroSalt is at varying stages of progress with these company's respective tasting, procurement, marketing and packaging departments and will keep the market informed of further developments.

 

About MicroSalt, Ltd

MicroSalt, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving peoples' lives with better-for-you seasonings and snacks by taking the lead in the industry by providing the best low-sodium salt solution, based on the mechanical transformation of the salt particle itself. This solution is the only one that delivers real salt flavour because it is salt. Our new patented technology produces salt crystals that are approximately one hundred times smaller than typical table salt, delivering a powerful saltiness as the micro-grains dissolve in the mouth, with approximately 50% less sodium consumption. Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavour consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc. To learn more about MicroSalt please visit www.microsaltinc.com.

To learn more about SaltMe! snacks please visit www.saltme.com

 

Tekcapital owns 97% of the share capital of MicroSalt Ltd. and 6,034,683 shares (78%) of MicroSalt Inc., its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

 Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon

microsalt@flagstaffcomms.com

 

+44 (0)207 129 1474

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving MicroSalt and/or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of MicroSalt and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of MicroSalt or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither MicroSalt nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRANKDBPCBKDFNB
Date   Source Headline
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
14th Mar 20197:00 amRNSInvestor conference call
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment
3rd Oct 20187:00 amRNSPublication of Research Note
2nd Oct 20187:01 amRNSGuident Ltd Appoints Chairman
2nd Oct 20187:00 amRNSPlacing to raise approximately $1.15million
17th Sep 20187:00 amRNSBelluscura PLC Expands its Patent Portfolio
7th Sep 20187:00 amRNSAppointment of Joint Broker
21st Aug 20182:04 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSMarketing & Technology Transfer Hub
3rd Aug 20187:00 amRNSLucyd Pte Ltd. Launches eShop
1st Aug 20187:00 amRNSSalarius Ltd Appoints CEO
4th Jul 20187:00 amRNSLucyd Pte Ltd. Update
29th Jun 20187:00 amRNSChange of Adviser
30th May 201812:53 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSHolding(s) in Company
22nd May 20187:00 amRNSLucyd Appoints Global Marketing Manager
22nd May 20187:00 amRNSSalarius Ltd Appoints Directors
17th May 20187:00 amRNSPrivate Placement for Belluscura plc
15th May 20181:17 pmRNSHolding(s) in Company
10th May 20187:00 amRNSHolding(s) in Company
8th May 20187:00 amRNSUniversity Technology Commercialization Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.